Pharmacokinetics study on cefoperazone and tazobactam compound injection in health volunteers

马瑞蓉,张慧琳,魏敏吉,赵彩云,侯杰,赵东方

DOI: https://doi.org/10.3969/j.issn.1001-8689.2003.11.012

2003-01-01

Abstract:Objective: To study the pharmacokinetics of a single dose of cefoperazone/tazobactam compound injection in health volunteers. Methods: Ten healthy volunteers were selected to receive a single dose of cefoperazone/tazobactam compound or cefoperazone alone within 30min infusion in an open randomized crossover study. The concentration of cefoperazone and tazobactam in serum and urine were determined by a high - performance liquid chromatography (HPLC) method. Results: Pharmacokinetic parameters were based on an open two - compartment model analyzed by using 3P97 and the results of HPLC method were as follows: the mean peak concentration (C max) of cefoperazone alone or in compound at the end of infusion were (181.52 ± 41.66) and (176.21 ± 32.66) mg/L respectively. The area under the concentration - time curve AUC 0.5-12 were (351.96 ± 54.53) and (336.31 ± 54.93)mg · h/L; AUC 0-12 were (402.21 ± 57.63) and (376.64 ± 55.18)mg · h/L;AUC 0-inf were (413.47 ± 59.06) and (395.83 ± 62.08)mg · h/L, respectively. The mean plasma elimination half-life(t 1/2β) were (2.23 ± 0.67) and (2.28 ± 0.61) h, respectively. The mean clearances(CL) were (4.06 ± 0.61) and (4.30 ± 0.79)1/h, respectively. The volume of distribution (Vd) were (6.52 ± 2.55) and (6.86 ± 3.27) L. respectively. The mean peak concentration(C max) of tazobactam at the end of infusion was (20.31 ± 4.76)mg/L. The area under the concentration - time curve AUC 0.5-5 was (12.96 ± 2.40) mg · h/L, AUC 0-5 was (18.45 ± 3.52) mg · h/L, AUC 0-inf was (19.42 ± 3.67) mg · h/L. The mean plasma elimination half - life(t 1/2β) was (0.84 ± 0.28)h. The mean clearances (CL) was (22.36 ± 4.08)l/h. The volume of distribution (Vd) was (11.49 ± 5.60) L. Urinary recovery rates of cefoperazone in cefoperazone/tazobactam and cefoperazone alone were (22.92 ± 7.79)% and (21.00 ± 7.33)% in 24h. Urinary recovery rate of tazobactam in cefoperazone/tazobactam was (60.56 ± 19.37)%. Conclusions: All volunteers were well tolerated in the single dose of 1600mg cefoperazone and cefoperazone/tazobactam (1600mg/400mg) given by iv infusion in 30min. Cefoperazone and tazobactam had no interaction when given together.